How many insider declarations does 以岭药业 have?

以岭药业 has filed 3 insider declarations with AMF.

Who is the top reporting insider at 以岭药业?

The top reporting insider at 以岭药业 is 张秋莲, based on the count of public filings.

What is the net insider buy vs sell volume on 以岭药业?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

以岭药业: management transactions · France · AMF

SZSE:002603FR·AMFMcap 28.5Bn€

AMF ↗

Browse the full directors' dealings record of 以岭药业, a listed equity based in France. Shares trade on FR FR, under the oversight of AMF. Market capitalisation: €28.5bn. The latest transaction was reported on 5 May 2023 — Sale. Among the most active insiders: 张秋莲. Every trade is openly available.

3

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

3 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

16.35 €

Income statement

Revenue7.83 Bn€

Gross profit5.03 Bn€64% margin

Net income1.29 Bn€16.4% margin

Balance sheet & cash

Market cap28.52 Bn€

Total debt25.7 M€

Free Cash Flow1.53 Bn€

Last declaration on 5 May 2023

All Executives3 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations